Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1100 CAD | 0.00% |
|
-4.35% | -15.38% |
| Market Cap | 41.54M 29.53M 25.64M 23.91M 21.96M 2.81B 42M 282M 110M 1.4B 111M 108M 4.65B | P/E 2026 * |
-3.67x | P/E 2027 * | -2.75x |
|---|---|---|---|---|---|
| Enterprise Value | 41.54M 29.53M 25.64M 23.91M 21.96M 2.81B 42M 282M 110M 1.4B 111M 108M 4.65B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.31x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -4.35% | ||
| 1 month | -15.38% | ||
| 3 months | -35.29% | ||
| 6 months | -29.03% | ||
| Current year | -15.38% |
| 1 week | 0.1 |  | 0.12 |
| 1 month | 0.1 | | 0.14 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.2 |
| 3 years | 0.1 | | 0.91 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 2024-08-11 |
James Parsons
DFI | Director of Finance/CFO | 60 | 2024-10-10 |
David Burke
IRC | Investor Relations Contact | - | 2024-10-10 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 2012-04-18 |
Steven Sangha
BRD | Director/Board Member | - | 2023-04-23 |
David Paterson
BRD | Director/Board Member | - | 2024-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/3/26 | Sell | Company | -115,000 | 0.0305% | ||
| 5/22/26 | Option | Director | 173,418 | 0.0499% | ||
| 2/27/26 | Option | Director | 377,970 | 0.1123% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -4.35% | -42.11% | -87.50% | 29.53M | |
| -1.54% | -3.07% | -11.93% | +18.42% | 129B | |
| +0.80% | -7.12% | -15.25% | +0.67% | 12.69B | |
| -0.20% | +12.69% | +94.89% | +129.15% | 10.05B | |
| -0.94% | -0.71% | -42.73% | -68.98% | 4.69B | |
| +1.17% | -0.67% | -12.11% | +36.19% | 2.62B | |
| -1.78% | +4.54% | +15.88% | -47.90% | 1.78B | |
| -1.51% | +4.23% | -28.97% | -31.15% | 1.68B | |
| -0.47% | +3.08% | -17.61% | -18.11% | 1.67B | |
| Average | -0.51% | +0.28% | -6.66% | -7.69% | 18.23B | |
| Weighted average by Cap. | -1.22% | -2.10% | -6.46% | +20.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.55M 3.09M 2.88M 2.64M 338M 5.05M 33.93M 13.26M 169M 13.35M 13.06M 560M |
| Net income | -12.83M -9.12M -7.92M -7.38M -6.78M -867M -12.97M -87.04M -34.03M -434M -34.25M -33.5M -1.44B | -19.77M -14.06M -12.21M -11.38M -10.45M -1.34B -19.99M -134M -52.45M -668M -52.79M -51.63M -2.21B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | CA$0.1100 | 0.00% | 276,571 |
| 26-07-31 | CA$0.1100 | 0.00% | 71,610 |
| 26-07-30 | CA$0.1100 | 0.00% | 3,157 |
| 26-07-29 | CA$0.1100 | -4.35% | 55,179 |
| 26-07-28 | CA$0.1150 | -4.17% | 21,084 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1100CAD
Average target price
0.4500CAD
Spread / Average Target
+309.09%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
